Details for New Drug Application (NDA): 021088
✉ Email this page to a colleague
The generic ingredient in VIADUR is leuprolide acetate. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
Summary for 021088
Tradename: | VIADUR |
Applicant: | Ortho Mcneil Janssen |
Ingredient: | leuprolide acetate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021088
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | IMPLANT;IMPLANTATION | Strength | EQ 65MG BASE | ||||
Approval Date: | Mar 3, 2000 | TE: | RLD: | No |
Expired US Patents for NDA 021088
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ortho Mcneil Janssen | VIADUR | leuprolide acetate | IMPLANT;IMPLANTATION | 021088-001 | Mar 3, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil Janssen | VIADUR | leuprolide acetate | IMPLANT;IMPLANTATION | 021088-001 | Mar 3, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil Janssen | VIADUR | leuprolide acetate | IMPLANT;IMPLANTATION | 021088-001 | Mar 3, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil Janssen | VIADUR | leuprolide acetate | IMPLANT;IMPLANTATION | 021088-001 | Mar 3, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription